MiR-590-5p Inhibits Oxidized-LDL Induced Angiogenesis by Targeting LOX-1

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Dai, Yao ^a,b   Zhang, Zhigao ^a   Cao, Yongxiang ^a   Mehta, Jawahar L ^b   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; MICRORNA; MIRN590 MICRORNA, HUMAN; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL MOVEMENT; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; SCAVENGER RECEPTORS, CLASS E;

EID: 84960153470     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22607     Document Type: Article

References (23)

1. Ho-Tin-Noe, B., Michel, J. B. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med 21, 183-187 (2011).
2. Li, S. et al. Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies. Invest Ophthalmol Vis Sci 56, 5210-5217 (2015).
3. Clarke, J. M., Hurwitz, H. I. Understanding and targeting resistance to anti-angiogenic therapies. J Gastrointest Oncol 4, 253-263 (2013).
4. Chen, K., Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8, 93-103 (2007).
5. Vecchione, A. et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci USA 110, 9845-9850 (2013).
6. Miranda, K. C. et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217 (2006).
7. Friedman, R. C., Farh, K. K., Burge, C. B., Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105 (2009).
8. Khaidakov, M. et al. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One 7, e47421 (2012).
9. Dandapat, A., Hu. C., Sun. L., Mehta. J. L. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol 27, 2435-2442 (2007).
10. Yu, S., Wong, S. L., Lau, C. W., Huang, Y., Yu, C. M. Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun 407, 44-48 (2011).
11. Ekhteraei-Tousi, S. et al. Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling. J Cell Biochem 116, 179-191 (2015).
12. Kornfeld, O. S. et al. Mitochondrial reactive oxygen species at the heart of the matter: New therapeutic approaches for cardiovascular diseases. Circ Res 116, 1783-1799 (2015).
13. Dai, Y. et al. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. Biochem Biophys Res Commun 437, 62-66 (2013).
14. Li, D. et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 41, 1048-1055 (2013).
15. Mehta, J. L., Chen, J., Yu, F., Li, D. Y. Aspirin inhibits oxLDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 64, 243-249 (2004).
16. Wang, X. et al. LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II. Cardiovasc Drugs Ther 28, 441-446 (2014).
17. Niu, J., Azfer, A., Zhelyabovska, O., Fatma, S., Kolattukudy, P. E. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 283, 14542-14551 (2008).
18. Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Fatma, S., Kolattukudy, P. E. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neo-vascularization and tumor growth. J Clin Invest 115, 2979-2991 (2015).
19. Vestweber, D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28, 223-232 (2008).
20. Khaidakov, M., Mitra, S., Mehta, J. L. Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid. J Cardiovasc Med (Hagerstown) 13, 187-193 (2012).
21. Etienne-Manneville, S. Adherens junctions during cell migration. Subcell Biochem 60, 225-249 (2012).
22. Chen, K. C. et al. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci 124, 4115-4124 (2011).
23. Dai, Y. et al. GLP-1 agonists inhibit ox-LDL uptake in macrophages by activating protein kinase A. J Cardiovasc Pharmacol 64, 47-52 (2014).